Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Clovis Oncology (GB:0A7C)
LSE:0A7C
Clovis Oncology (0A7C) Share Price & Analysis
0 Followers
0A7C Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.01 - $1.15
Previous Close$0.01
Volume0.00
Average Volume (3M)N/A
Market Cap
$2.17M
Enterprise Value$382.17M
Total Cash (Recent Filing)$58.32M
Total Debt (Recent Filing)$438.32M
Price to Earnings (P/E)N/A
Beta2.65
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,804
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.87
Enterprise Value/Gross Profit3.66
Enterprise Value/Ebitda-1.80
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
0A7C FAQ
What was Clovis Oncology’s price range in the past 12 months?
Clovis Oncology lowest share price was $0.01 and its highest was $1.15 in the past 12 months.
What is Clovis Oncology’s market cap?
Currently, no data Available
When is Clovis Oncology’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Clovis Oncology’s earnings last quarter?
Currently, no data Available
Is Clovis Oncology overvalued?
According to Wall Street analysts Clovis Oncology’s price is currently Overvalued.
Does Clovis Oncology pay dividends?
Clovis Oncology does not currently pay dividends.
What is Clovis Oncology’s EPS estimate?
Clovis Oncology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clovis Oncology have?
Currently, no data Available
What happened to Clovis Oncology’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Clovis Oncology?
Among the largest hedge funds holding Clovis Oncology’s share is Gamco Investors, Inc. ET AL. It holds Clovis Oncology’s shares valued at N/A.
---
Clovis Oncology Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of cancer treatments. Its marketed product Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is offered for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO.
---
0A7C Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering 0A7C
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+92.80%
downgraded a sell rating a year ago
Copying Brian Cheng's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +92.80% per trade.
---